In 2023, Navigator Holding Tissue completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Navigator Holding Tissue has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy/Paste is a PRO feature. | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Navigator Holding Tissue’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Navigator Holding Tissue amounted to 3,092.496 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Navigator Holding Tissue decreased by 6.44%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2023, the total Scope 1 emissions of Navigator Holding Tissue were 268.933 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2022), Navigator Holding Tissue's Scope 1 emissions decreased by 8.54%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2023, Navigator Holding Tissue reported Scope 2 greenhouse gas (GHG) emissions of 2,823.563 tCO₂e without specifying the calculation method.a
Compared to the previous year (2022), Navigator Holding Tissue's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Navigator Holding Tissue's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2023, Navigator Holding Tissue reported its Scope 2 emissions using an unspecified methodology.a
In 2023, Navigator Holding Tissue reported 10.344 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2023 disclosure of Navigator Holding Tissue includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2023, Navigator Holding Tissue reported total Scope 3 emissions of 10.344 metric tons of CO₂ equivalent (tCO₂e).a
In 2023, Navigator Holding Tissue reported a total carbon footprint of 3,102.84 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 6.12% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Navigator Holding Tissue's total carbon footprint was Scope 2 emissions, accounting for 91% of the company's total carbon footprint, followed by Scope 1 emissions at 8.67%.a